ITW vs LAB · P/E 22, rev $16.04B vs rev $174.4M
Illinois Tool Works Inc (ITW) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Illinois Tool Works Inc (ITW) is a specialty industrial machinery company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported ITW revenue for 2025-12-31 was $16.04B. Net income was $3.07B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. ITW currently screens at market cap $72.53B and trailing P/E 21.8.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
ITW currently screens at market cap $72.53B and trailing P/E 21.8. LAB currently screens at market cap $317.1M.
Not investment advice. Open the ITW and LAB stock pages for the full models.
Not investment advice.